Hepatitis C treatment may soon be made easier by new medication combination
(dailyRx News) Hepatitis C patients may soon have a much more effective and simple treatment. One recent study showed that combining two new medications was safe and reduced the amount of active virus in patients.
This study showed a very high rate of success treating both new patients and those who had been treated with other medications previously. The researchers used both sofosbuvir (Sovaldi), which was recently approved by the FDA, and daclatasvir, which is still awaiting approval, to treat both men and women diagnosed with hepatitis C.
After three months of treatment with this medication combination, a majority of the patients in this study showed no signs of hepatitis C in their blood.
Read more from RxWiki HERE.